CClinicalTrials.gg
CompletedNCT04014816Updated Jul 10, 2019

Gastrointestinal Dysfunction During Enteral Nutrition in Critically Ill Patients

An observational study in Gastrointestinal Disease, Constipation and Intolerance; Nutritional, sponsored by Ayancık State Hospital. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-07-10.

Sponsored by Ayancık State Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
137
Ages
18 Years and older
Sex
All
01

Study summary

Gastrointestinal (GI) motility disorders in intensive care patients remain relatively unexplored. Nowadays, the frequency, risk factors and complications of GI dysfunction during enteral nutrition (EN) become more questionable. Our aim is to evaluate the frequency, risk factors and complications of GI dysfunction during EN in the first 2 weeks of the intensive care unit (ICU) stay and to identify precautions to prevent the development of GI dysfunction and avoid complications.

Read the detailed description

Critical illness is typically associated with a catabolic stress state in which patients demonstrate a systemic inflammatory response coupled with complications of increased infectious morbidity, multiple organ dysfunction, prolonged hospitalization, and disproportionate mortality. Suspension of feeding and the resultant inability to reach nutritional goals is one complication of gastrointestinal (GI) dysfunction, but there are others (mucosal barrier disruption, altered motility, atrophy of the mucosa, and reduced mass of gut-associated lymphoid tissue) that may explain the greater length of stay (LOS) and death rate with GI dysfunction. In Europe and the United States, nutritional administration guidelines recommend primarily enteral nutrition (EN) for hemodynamically stable intensive care unit (ICU) patients. Providing EN in these patients has been shown to be superior to parenteral nutrition. GI complications such as constipation, delayed gastric emptying, diarrhea, and vomiting may occur in up to 50% of mechanically ventilated patients and adversely affect ICU mortality and LOS. Nevertheless, there is no consensus for obtaining a precise assessment of GI function.Diagnosis of GI dysfunction in ICU patients is complex and relies on clinical symptoms. Lack of validated markers of GI system dysfunction is often misdiagnosed and poorly managed in the ICU. The role of nutrition in critical illness is important, but there is an increasing evidence and broadening consensus that aggressive early feeding as well as prolonged underfeeding both should be avoided. Avoidance of complications like malnutrition, aspiration of gastric contents, wound infections, and decubitus through GI dysfunction is an important part of management of patients with GI failure.

02

Conditions studied

  • Gastrointestinal Disease
  • Constipation
  • Intolerance; Nutritional
  • Diarrhea

Keywords

  • ICU
03

In context

Gastrointestinal Diseases

628 studies on the registry are indexed under Gastrointestinal Diseases; 128 are open to participants now.

This study's enrollment of 137 is below the median of 325 across 190 observational studies indexed under Gastrointestinal Diseases.

Browse Gastrointestinal Diseases studies →

Lead sponsor

Ayancık State Hospital is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

In this prospective observational study, 137 out of 226 patients consecutively admitted into a mixed medical-surgical ICU from 1 January 2015 to 31 June 2015 were enrolled.

Inclusion criteria

Older than 18 years old. Stay longer than 48 hours at ICU.

Exclusion criteria

Exclusion Criteria:

Has enterostomy/colostomy or diagnosis of GI bleeding. Prone position. Laxative drug use. Clostridium Difficile infection positivity.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
137 participants (actual)
Patient registry
No

Groups and cohorts

  • Group I

    Patients who had GI dysfunction (Group I) for one or more occasions.

    Other: MDR bacteria positivity · Other: negative fluid balance

  • Group II

    Patients who had normal GI function (Group II) for one or more occasions.

    Other: MDR bacteria positivity · Other: negative fluid balance

Interventions

  • OtherMDR bacteria positivity

    A total of 137 patients who received nasogastric tube feeding in an ICU of a tertiary hospital were enrolled.

  • Othernegative fluid balance

    A total of 137 patients who received nasogastric tube feeding in an ICU of a tertiary hospital were enrolled.

06

What researchers measure

Primary outcomes

  1. The incidence of GI dysfunction

    Constipation, diarrhea, UDI

    Time frame: up to 14 days.

Secondary outcomes

  1. The sequential organ failure assessment(SOFA) score

    SOFA Score is a mortality pre-score that is based on the degree of dysfunction of six organ systems. Each organ system is assigned a point value from 0 (normal)to 4 (high degree of dysfunction/failure). The SOFA score ranges from 0 to 24.The highest SOFA score correlates with highest mortality rates. Scores of more than 11 corresponded to mortality of more than 80%.

    Time frame: at admission.

  2. Hypoalbuminemia

    below 2,5 g/dl

    Time frame: up to 14 days.

  3. Catecholamine use

    mcg

    Time frame: up to 14 days.

  4. Length of hospital stay

    days

    Time frame: through study completion, which is 6 months time period.

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Atasever AG, Ozcan PE, Kasali K, Abdullah T, Orhun G, Senturk E. The frequency, risk factors, and complications of gastrointestinal dysfunction during enteral nutrition in critically ill patients. Ther Clin Risk Manag. 2018 Feb 23;14:385-391. doi: 10.2147/TCRM.S158492. eCollection 2018. PubMed 29503558 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 10, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04014816
Lead sponsor
Ayancık State Hospital
Responsible party
Ayse Gulsah Atasever (Anesthesiology Specialist, Ayancık State Hospital) — Principal investigator
First posted
Jul 10, 2019
Start date
Jan 1, 2015
Primary completion
Jul 1, 2015
Completion
Jul 1, 2015
Last update
Jul 10, 2019

Study contacts

Evren Senturk, Assoc. Prof
study director · Koc University Hospital, Istanbul

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion